Home - Australian Pharmacist

Metformin for wet (neovascular) age-related macular degeneration

Dr Esther Lau and Prof Lisa Nissen - June 12, 2000

CPD

References Khanna S, Shaw L, Hyman MJ, et al. Association of metformin use with risk of newly onset neovascular age-related macular degeneration development. Retina...

James Chalmers and Peter Guthrey MPS - August 9, 2000

Industry

Pharmacy practice is rapidly evolving. Here’s how the drastically reimagined Professional Practice Standards can help the profession adapt.

Changes to AIR information – DO NOT USE

AP Staff - April 18, 2000

Clinical

Changes to AIR information

AP Staff - April 18, 2000

Clinical

References 1. Australian Government Department of Health and Aged Care. Mandatory reporting changes to the Australian Immunisation Register (AIR) from 1 March 2024. 2024. At:...

Pharmacist prescribing of melatonin

Karen Castle MPS - September 13, 2000

Clinical

Melatonin is a naturally occurring hormone responsible for regulating the body’s circadian rhythm. Supplemental melatonin can help to reinforce the circadian rhythm, making it useful for treatment of insomnia and jet lag.

Forget sheep, wheat & gold

Dr Leigh Dayton - July 11, 2000

Clinical

Eucalyptus oil was Australia’s first product export.

1...281282283...285 Page 282 of 285

Who is most at risk?

How should pharmacists assess and manage falls risk?

What impact can dose have on falls risk?

When is a discussion with the prescriber warranted?

Be wary of using ‘wonder drugs’ in older patients

Involve older patients in deprescribing decisions

Warranted distrust in medicines and healthcare needs to be built back up

Pharmacists can bridge communication and healthcare gaps in RACFs

Transcript

Our speakers

Will the packaging change?

What should pharmacists do if they get a Phenergan script for an 18 month old infant?

Is there any situation where it would be appropriate to dispense Phenergan to a young child?

What about prescribing Phenergan as a Schedule 3 medicine?

What about phenylephrine?

What advice should pharmacists provide?

Who is most at risk?

How should pharmacists assess and manage falls risk?

What impact can dose have on falls risk?

When is a discussion with the prescriber warranted?

Be wary of using ‘wonder drugs’ in older patients

Involve older patients in deprescribing decisions

Warranted distrust in medicines and healthcare needs to be built back up

Pharmacists can bridge communication and healthcare gaps in RACFs

Transcript

Our speakers

Will the packaging change?

What should pharmacists do if they get a Phenergan script for an 18 month old infant?

Is there any situation where it would be appropriate to dispense Phenergan to a young child?

What about prescribing Phenergan as a Schedule 3 medicine?

What about phenylephrine?

What advice should pharmacists provide?

Who is most at risk?

How should pharmacists assess and manage falls risk?

What impact can dose have on falls risk?

When is a discussion with the prescriber warranted?

Be wary of using ‘wonder drugs’ in older patients

Involve older patients in deprescribing decisions

Warranted distrust in medicines and healthcare needs to be built back up

Pharmacists can bridge communication and healthcare gaps in RACFs

Transcript

Our speakers

Will the packaging change?

What should pharmacists do if they get a Phenergan script for an 18 month old infant?

Is there any situation where it would be appropriate to dispense Phenergan to a young child?

What about prescribing Phenergan as a Schedule 3 medicine?

What about phenylephrine?

What advice should pharmacists provide?

Who is most at risk?

How should pharmacists assess and manage falls risk?

What impact can dose have on falls risk?

When is a discussion with the prescriber warranted?

Be wary of using ‘wonder drugs’ in older patients

Involve older patients in deprescribing decisions

Warranted distrust in medicines and healthcare needs to be built back up

Pharmacists can bridge communication and healthcare gaps in RACFs

Transcript

Our speakers

Will the packaging change?

What should pharmacists do if they get a Phenergan script for an 18 month old infant?

Is there any situation where it would be appropriate to dispense Phenergan to a young child?

What about prescribing Phenergan as a Schedule 3 medicine?

What about phenylephrine?

What advice should pharmacists provide?

Subscribe to our newsletter

Subscribe to our newsletter

CONTACT

FOLLOW US